Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daosin is a branded dietary supplement containing the enzyme diamine oxidase (DAO), which is responsible for breaking down histamine in the intestine. It is used for the dietary management of DAO deficiency and histamine intolerance, conditions where insufficient DAO activity leads to elevated levels of histamine from food, resulting in symptoms such as migraines, digestive issues, and skin reactions. The supplement provides exogenous DAO—typically derived from pig kidney protein extract—to complement or restore deficient endogenous enzyme activity. By increasing intestinal DAO levels when taken before meals, Daosin enhances the breakdown of ingested histamine and may reduce symptoms associated with histamine intolerance[1][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on daosin.